June has seen to lowest volume traded over the past year by far....

June has seen to lowest volume traded over the past year by far. This would usually mean lack of interest, faith, trust etc.
Although in the case of LCT, where the volume in the lead up to completion of the clinical phase of the current trial was triple that of June, I see this a huge sign of confidence by current shareholders. Very few holders are willing to part with a single share at the current offer this close to the release of (likely positive) results.
I know this is a bias opinion as I’ve been following this company for some time, but this is the way I read it….